GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Incomplete blinking is associated with meibomian gland dropout, meibum quality, and lipid layer thickness, and may predict DED.

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with inflammation of the eye's iris ... correlation between anterior ...

Dr. Neda Nikpoor is an ophthalmologist with Jenkins Eye Care. She sits on an advisory board with Project Vision which regularly does screenings in our schools. The Conversation talked with her about ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis.